Bristol-Myers Squibb Net Worth 2006-2019 | BMY

Interactive chart of historical net worth (market cap) for Bristol-Myers Squibb (BMY) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Bristol-Myers Squibb net worth as of September 20, 2019 is $82.72B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $82.721B $22.561B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $347.446B 15.13
Roche Holding AG (RHHBY) Switzerland $244.560B 0.00
Merck (MRK) United States $218.042B 17.93
Pfizer (PFE) United States $202.934B 11.95
Novartis AG (NVS) Switzerland $199.547B 17.17
Novo Nordisk (NVO) Denmark $125.362B 22.15
AstraZeneca (AZN) United Kingdom $118.542B 22.93
Sanofi (SNY) France $116.342B 14.30
Eli Lilly (LLY) United States $112.145B 20.93
AbbVie (ABBV) United States $107.027B 8.58
GlaxoSmithKline (GSK) United Kingdom $103.834B 13.05
Bayer (BAYRY) Germany $69.046B 10.06
H Lundbeck (HLUYY) Denmark $7.123B 10.28